Pfenex Inc.

Dow Agrosciences LLC

Dow Global Technolgoies LLC

Charles H. Squires

Diane M. Retallack

David C. Watkins

Frank H. Gaertner

Robert Shutter

Stacey Lynn Lee

Frank H Gaertner

Diane M Retallack

David K Watkins

Charles H Squires

David C Watkins

The invention is a process for improved production of a recombinant mammalian protein by expression in a Pseudomonad, particularly in aorganism. The process improves production of mammalian proteins, particularly human or human-derived proteins, over known expression systems such asin comparable circumstances. Processes for improved production of isolated mammalian, particularly human, proteins are provided.

[object Object]

The invention is a process for improved production of a recombinant mammalian protein by expression in a Pseudomonad, particularly in aorganism. The process improves production of mammalian proteins, particularly human or human-derived proteins, over known expression systems such asin comparable circumstances Processes for improved production of isolated mammalian, particularly human, proteins are provided.

The present invention provides active cytokine and/or chemokine compositions, as well as inexpensive means for the production, amended-cell encasement of active cytokine and/or chemokine compositions, processing, and delivery of active cytokine and/or chemokine compositions. The subject invention also provides methods of treatment and methods of accelerating an immune response comprising the administration of amended recombinant cell (ARC) containing cytokine and/or chemokine compositions to animals or humans.

Amended recombinant cells for the production and delivery of gamma interferon as an antiviral agent, adjuvant and vaccine accelerant

Growing community of inventors

Poway, CA, United States of America

Robert Shutter